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INTRODtJCTION
In dealing with reactions of living organisms to tobacco and
tobacco smoke, we are inevitably faced with two types of re-
€ponses, (a) the pharmacological reactions to nicotine and various
substances contained in smoke, (b) allergy to the pharmacological
agents themselves, (c) hypersensitiveness in the ordinary sense
to the allergenic substances contained in the tobacco leaf, the
latter being similar to sensitization with ragweed pollen or horse
dander.
The pharmacological effect of smoking several cigarettes has
been shown by Maddock, Malcolm and Coller (1), Lampson (2),
Mann (3) and others, to result in a decrease of skin temperature
of the fingers and toes, due to vaso-constriction, diminution in
blood flow, increase in blood pressure and pulse rate in the same
degree as was obtained by nicotine injected intravenously, in
amount theoretically absorbed in the smoking of one or two
cigarettes. The character of the response was shown to be
identical in both men and women. Nor was there any difference
noted in this respect in normal individuals and those suffering
from peripheral vascular disease such as thrombo-angiitis ob-
literans. That these results were brought about through the
action of nicotine on the autonomic nervous system was clearly
demonstrated by Maddock et al, by anesthetizing the nerve
1 From the Laboratories and Medical Departments, Mount Sinai Hospital,
New York City.
Read before the Second Annual Meeting of the Society for Investigative Der-
matology Inc., St. Louis, May 16, 1939.
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supply to the test area and thus abolishing the vaso-constrictor
effect, as compared with the unanesthetized control sites.
In view of the fact that normal individuals who smoke just
as much as those who develop symptoms from tobacco, are sub-
jected to the same nicotine effects, it is questionable whether
we should attribute the resulting pathological reactions in the
latter solely to the pharmacological action of smoking or nicotine.
By analogy we cannot ascribe to the common pharmacologic
laxative effect of phenolphthalein the production following its
ingestion of a fixed skin eruption in certain individuals. It
follows therefore that the untoward effects from tobacco may be
connected with some mechanism other than pharmacological
which renders some persons more vulnerable to its use than others.
The one which suggests itself most prominently is that of allergy.
The various possibilities in this regard as above intimated are
on the one hand, hypersensitiveness to the pharmacological agent
per se or in combination with tobacco protein, and on the other
an interplay of action wherein hypersensitiveness to tobacco
allergens enhances the effect of nicotine. Inasmuch as our
current knowledge of even the simplest steps in the allergic re-
actions to foreign proteins does not embody sufficient information
to elucidate all of the features involved, it is impossible at this
stage in the study of so complicated a human response as that
to tobacco, to account adequately for the role of each of the
participating factors. Investigations of sensitization to nicotine
in twelve patients, by means of skin tests with a 10 per cent solu-
tion of nicotine tartrate in dilutions of 1: 10,000 and 1:5000
carried out by the author (4) as well as those of Sulzberger (5)
have thus far yielded negative results. Fully realizing however,
that in spite of this neither the factor of hypersensitiveness nor
the pharmacological influence of nicotine can be entirely divorced
from the appraisal of clinical effects resulting from smoking,
we have nevertheless focused our studies for the present to
phases of tobacco reactions more intimately connected with the
classical immunological processes capable of objective analysis
by established clinical and experimental methods.
The discovery a number of years ago that patients suffering
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from pollen hay fever and asthma gave positive reactions to
pollens and other allergens having a direct bearing in the elicita-
tion of these symptoms, gave an impetus to the utilization of
skin testing as a technique in the study of other allergic mani-
festations. It was gradually discovered however, that undoubted
instances of food hypersensitiveness, eczema, urticaria, angio-
neurotic edema, as well as about 50 per cent of asthmatics did
not always yield positive skin reactions. Furthermore it was
shown that many positive reactions did not necessarily indicate
clinical hypersensitiveness even though they were accompanied
by the presence of reagins demonstrable by passive transfer,
nor was the size of a reaction always a measure of the degree of
clinical sensitiveness.
These facts about skin reactions were corroborated by the
experience of many allergists, and were moreover augmented by
investigations as to the incidence of skin reactions to various
standard allergens in so-called normal controls by Grow and
Herman (6), Rackeman and Simon (7), Harkavy and Romanoff
(8, 9), as well as Pearson (10).
Their studies disclosed: (a) that between 40 to 50 per cent of
so-called normal controls gave positive reactions to various
combinations of test substances of undoubted reliability such as
ragweed and timothy pollens, wheat, milk, etc., (b) that approxi-
mately 30 per cent of these individuals turned out to be allergic
themselves or offsprings from allergic families. The positive
skin tests given by the latter group, independently of clinical
hypersensitiveness could be attributed to the inherited capacity
of such individuals to develop reactions to various substances
after repeated exposure, and thus indicated an immune response
on the part of the skin in the absence of a specific shock organ.
That this type of person may be found even in a much larger
proportion of the general population than has hitherto been
generally recognized is disclosed in a very recent survey as to the
incidence of allergy in a thousand families in Colorado Springs
made by W. C. Service (11). This investigation revealed that
505 or 50.5 per cent of the families had one or more members who
evidenced major allergic manifestations.
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Positive skin reactions in the non-allergic group could be
explained on the ground that some of these individuals may
have originated from allergic stock without knowing it or else
might have developed reactions from previous repeated contact
with the substance tested.
In view of these facts, the difficulties in evaluating skin re-
actions both in allergic and non-allergic persons, unless supported
by clear cut clinical histories of symptoms which can be corre-
lated with the reacting allergens, led to the formulation of certain
basic criteria for the recognition of the etiologic role of a reacting
agent. These represent the essence of many observations on
the behaviour of specific allergens in undoubted instances of
hypersensitiveness and may be summarized as follows: First,
the test substance must be shown to be non-irritative in nature
and therefore give negative reactions in non-allergic individuals
having had no previous contact with it. Second, positive reac-
tions should be accompanied by specific reagins at least in some
of the reacting individuals. Third, intradermal injection of the
allergen should be followed by local eosinophilic response in the
urticarial wheal of the immediate reaction, characteristic of
allergic tissue responses. Fourth, it should be possible to elicit
clinical symptoms in the patient after exposure to the reacting
substance and cause their disappearance upon its withdrawal.
While the first three postulates may not always be satisfied the
fourth is the sine qua non for the establishment of allergic etiology.
In our investigation of the rOle of tobacco in disease from the
point of view of allergy we have satisfied every one of these pre-
requisites. The evidence which we have to present is the out-
growth of our investigations of the incidence of skin reactions
to tobacco in (a) 400 normal smokers, male and female, (b) 126
adult female non-smokers, both of which groups corresponded
in age to that of our cases of thrombo-angiitis obliterans, (c)
319 control smokers consisting of 47 normal and 292 adult pa-
tients suffering from various ailments, (d) 140 cases of thrombo-
angiitis obliterans, (e) 31 cases of peripheral vascular disease
associated with arterio-sclerosis and (f) 100 cases of coronary
disease with angina peetoris.
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We have chosen as our primary subject for the study of tobacco
allergy, the symptoms complex of thrombo-angiitis obliterans
because it represents vascular involvement uncomplicated by
arterio-sclerosis, the etiology of which is obscure, but in which
the role of tobacco has been debated for fifty years. The typical
disease occurs in young men, under 45 years of age, who smoke
excessively. Our youngest patient studied was 18 years old.
The question which confronted us was, if tobacco plays a re-
sponsible part in this affliction then why do not others who smoke
as much also develop this disease. Is it possible that the answer
is to be found in tobacco hypersensitiveness in patients whose
shock tissue is essentially localized in the blood vessels?
To solve this question we prepared a series of five different
tobacco extracts of the denicotinized cured leaves of Burley,
Maryland, Virginia, Xanthis and Havana tobaccos, for intra-
dermal testing, using a modified Coca method of extraction.
Ragweed, timothy pollen and horse dander were also employed
as control antigens in order to check the allergenic constancy of
our tobacco extracts. This was suggested by the fact that in
testing control smokers and non-smokers, positive reactions to
tobacco were obtained whenever an individual reacted to rag-
weed and less frequently, to timothy pollen. This remarkable
parallelism occurring irrespectively of clinical hypersensitiveness
to any of these test substances was accompanied as a rule by the
presence of corresponding reagins demonstrable by passive
transfer. These observations which have been recently cor-
roborated by Peshkin (12) in his studies of tobacco reactions
in allergic and non-allergic children, also served as a guide which
led to more searching inquiry into the histories of the tested
controls and helped to uncover the existence of atopic hyper-
sensitiveness.
The results obtained in testing 400 normal unselected adult
smokers consisting of 300 males and 100 females, with five differ-
ent tobaccos, ragweed and timothy pollens as well as horse dander
and 125 adult non-smokers were as follows.
Of the 400 control smokers 32 per cent reacted to various
combinations of ragweed, timothy, horse dander and tobacco;
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9 per cent reacted to tobacco only. Of the 126 control non-
smokers, 12 per cent reacted to tobacco, ragweed and birch
pollen. Of these, eleven patients or 9.2 per cent reacted to
tobacco only.
A comparison between these two groups indicates that there
were almost three times as many tobacco reactors amongst
smokers as there were among the non-smokers. This of course
corroborates the known fact that repeated exposure to a given
antigen is frequently followed by the development of skin reac-
tions.
In the early stages of our investigation in place of using as
controls normal smokers who had no symptoms from tobacco,
which is obviously the only legitimate standard of comparison
with smokers who develop disease from tobacco, we investigated
319 smokers who were patients in the wards of the hospital, in
order to determine the incidence of tobacco reactions among
them as compared with those suffering from thrombo-angiitis
obliterans. We tried to exclude from this group atopic indi-
viduals because only about 10 per cent of our cases with Buergers
disease gave a history of atopy. This however, turned out to
be an error, because many of the ward patients had no knowledge
of their personal or family histories and exclusion of the ones
who admitted to being allergic, merely lowered our total per-
centage, without giving us a true picture of the actual number of
reactors to tobacco and pollens in a general patient population
other than that with thrombo-angiitis obliterans. It did how-
ever, serve one very important purpose, and this was the discovery
that of the 319 patients tested 20 per cent who reacted to tobacco
either alone or in combination with pollens etc., manifested
several important clinical conditions in which tobacco frequently
plays a contributary or possibly even an exciting role. The first
was coronary artery disease with angina pectoris and the second,
gastric and duodenal ulcer. Inasmuch as we were especially
interested in diseases of blood vessels, these findings led to a
more detailed investigation of patients with coronary artery
disease in addition to various other types of vascular disease, the
major group of which was represented by thrombo-angiitis ob-
literans.
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A comparison of the findings in 140 cases of thrombo-angiitis
obliterans tested with five tobacco extracts, ragweed, timothy
and horse dander and normal control smokers revealed the
following facts. Ninety-five patients or 68 per cent gave posi-
tive reactions to tobacco only, ranging from one plus and over in
contrast to 9 per cent to tobacco only, in the normal control
smokers and non-smokers. A ratio of seven to one. Fifteen
patients with thrombo-angiitis obliterans or 10 per cent, reacted
to various combinations of ragweed, timothy and horse dander
as compared with 32 per cent of the normal control smokers and
3 per cent of the non-smokers. It should be noted that the
latter figure is probably higher because in testing this non-smoker
group we excluded those who gave histories of atopy, whereas
no such selection was made in the 400 control smokers.
If we were to add to the 95 positively reacting patients with
thrombo-angiitis obliterans, fourteen others who gave plus minus
reactions to tobacco, we would have an increase from 68 per cent
to a total of 78 per cent of patients giving positive reactions to
tobacco only, as compared with 9 per cent to tobacco only in the
400 normal unselected control smokers. The justification in
regarding a plus minus reaction with our tobacco extracts as
specific, has been recently corroborated by Peshkin (12), who
showed that 42 per cent of children who gave plus minus reac-
tions to these extracts had corresponding reagins demonstrable
on passive transfer.
Forty-four per cent of the ninety-five cases of thrombo-
angiitis obliterans giving positive tobacco reactions of one plus
and over showed tobacco reagins (antibodies) on passive transfer.
This percentage would have probably been greater if more trans-
fers had been performed. Sulzberger (13) in his studies of
tobacco sensitiveness in a relatively small series of cases of
thrombo-angiitis obliterans obtained 77 per cent of positive
reactions and 36 per cent in his control smokers. These figures
are comparable to our total of 78 per cent, if the 10 per cent who
gave plus-minus reactions are included, and 41 per cent in our
controls consisting of 32 per cent reactors to tobacco, ragweed,
timothy and horse dander and 9 per cent to tobacco only. The
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unpublished figures of Romanoff and Rubin (14) dealing with 52
cases of thrombo-angiitis obliterans indicate a total of 50 per cent
reacting to tobacco only of one plus and over as compared with
16 per cent to tobacco only in 68 normal controls and a total of
69 per cent in the thrombo-angiitis obliterans group as compared
with 36 per cent in controls to tobacco and other allergens.
Green (15) who investigated a similar group of 44 cases with
thrombo-angiitis obliterans found 68 per cent positive to tobacco
only giving reactions of one plus and over and a total of 80 per
cent including those who gave plus minus reactions as well.
Westcott and Wright (16) in a study of 35 typical cases of
thrombo-angiitis obliterans reported 71 per cent positive reactions
to tobacco. These included reactions which were read as "slight
and slightly moderate" corresponding to our one and two plus
reactions. Exclusion of the latter, left 42.8 per cent of patients
giving tobacco reaction over two plus. Such figures compare
with our total of 68 and 43 per cent respectively using a similar
basis of reading. In contrasting their results with those ob-
tained in a so-called group of controls, they found that the latter
gave almost a similar percentage of positive reactions. They
therefore conclude from their findings that since patients with
thrombo-angiitis obliterans did not show a greater number of
positive reactions than the control group the "high incidence
reported by other investigators and interpreted as allergic reac-
tions is considered due to some of the many non-specific reactions
from chemical irritation. Hence thrombo-angiitis obliterans
is not caused by an allergic type of tobacco hypersensitiveness."
Analysis of their protocols, on which they base these conclu-
sions reveals that with the exception of four normal individuals,
two of whom reacted to tobacco, the types of cases which they
chose as controls consisted of patients who presented vascular
syndromes previously reported to us as additional forms of clini-
cal manifestations of tobacco hypersensitiveness, other than
thrombo-angiitis obliterans.
Thus for example 21 out of their 35 controls who reacted posi-
tively to tobacco presented the following forms of vascular
involvement. Eight cases whose average age was 53 had periph-
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eral vascular disease, seven of these were associated with early
arterio-sclerosis and one with arthritis. Some of these cases
aged 45, 47 and 50 may very well correspond to our borderline
or late cases of thrombo-angiitis obliterans, in whom tobacco
certainly plays an important synergistic role. Three cases,
averaging 30 years of age were diagnosed as vaso-motor instability
and two of these were designated as "Raynauds syndrome"?
One case aged 36 which showed varicose ulcers associated with
"venous obstruction," could represent some form of phlebitis
associated with tobacco hypersensitiveness in which the ulcers
were merely end results of the venous obstruction. Four cases
had coronary artery disease, two asthma, and one migraine.
Since the majority of these patients were smokers, tobacco could
readily be of allergenic significance and positive reactions a
normal sequence. It is obvious therefore that the use of such
material as controls, in an investigation of tobacco allergy, is
comparable to a study of egg hypersensitiveness in bronchial
asthma and the employment of patients with eczema, gastro-
intestinal allergy, vaso-motor rhinitis and hay fever as controls.
A logical re-interpretation of their findings of 71 per cent
positive reactions of one plus and over in 35 cases of thrombo-
angiitis obliterans, seems therefore not only to corroborate our
own figures of 68 per cent in 140 similar cases but the demon-
stration of positive reactions to tobacco in the so-called controls
composed mostly of cases with various kinds of vascular disease
and typical allergic manifestations such as asthma and migrain
are obviously also in agreement with our own published observa-
tions in such cases.
In contrast to the confirmatory findings of Sulzberger, Roman-
off and Rubin, Green, Westcott and Wright as to the incidence
of tobacco reactions in thrombo-angiitis obliterans the results
published by Trasoff (17), show only 16 per cent of positive
reactions to tobacco in 31 cases of "proved cases of thrombo-
angiitis obliterans." Careful perusal of his paper however,
fails to show any evidence of this proof. As a matter of fact the
only description given of the patients studied is that "eighteen
cases were under fifty and thirteen were over fifty years of age"
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and that the duration of the disease in these cases varied from
six months to 21 years. The question which at once arises is,
which of the cases had their disease six months, those over fifty
or under fifty? Surely the former cannot be classed as having
typical thrombo-angiitis obliterans, especially if they had their
symptoms for six months in view of the well recognized fact that
this disease occurs as a rule in patients under 45. Inasmuch as
no other description of the character of the patients studied by
this author is available and no information is given as to whether
the cases of 21 years duration which might have been thrombo-
angiitis obliterans, or those of six months duration were the ones
that gave the 16 per cent positive skin reactions to tobacco which
he obtained, it is impossible to evaluate any of these results. In
dealing with 40 normal smokers Trasoff found that 7 or 17 per
cent of these gave positive skin reactions to tobacco. Of these
there were three, who were constitutionally allergic. These
results compare favorably with our 11 per cent and 16 per cent
obtained by Romanoff and Rubin.
The second group of vascular disease studied, were cases of
coronary artery disease with and without angina pectoris. Of
100 cases examined, approximately 44 per cent gave positive
reactions to tobacco. Out of 14 selected for passive transfer,
11 or 71 per cent had tobacco reagins demonstrable on passive
transfer. Inquiry into the past of these patients disclosed that
33 per cent had histories of allergy. This contrasted with 10
to 12 per cent in a group of 140 cases of thrombo-angiitis ob-
literans and 25 per cent obtained in a group of 400 normal un-
selected control smokers in the general population. This high
incidence of histories of allergy in cases with coronary artery
disease is striking in view of the frequent occurrence of bronchial
asthma and so-called cardiac asthma in these patients. In the
light of some recent observations which we have reported, this
fact may give a different interpretation to the pathogenesis of
certain types of asthma as well as some varieties of coronary
artery disease.
The significance of the predominance of tobacco skin reactions
in thrombo-angiitis obliterans as well as in the coronary artery
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group of patients lies in the relation it bears upon the clinical
role of tobacco in both of these conditions. It has been repeatedly
demonstrated by Silbert and others that discontinuance in the
use of tobacco in the early cases of thrombo-angiitis obliterans
is followed by the complete arrest in the progress of this disease.
Resumption of smoking brings about a return of symptoms. In
patients sensitive to tobacco who have angina pectoris with or
without coronary artery sclerosis, in our experience and that of
many others, tobacco can definitely induce angina. In this
connection we wish to emphasize that we are referring to the
I II III
FIG. 1. (I) 7/19/36. E.C.G. normal.(II) 4/6/38. E.C.G. taken after three attacks of severe angina pectoris on
April 1, 3 and 5, 1938, during a period of continued smoking. There is an inversion
of Ti and T4, semi-inversion of T2, suggestive of anterior wall infarction. (4/6/38.
Patient stopped smoking.)(III) 4/16/38. E.C.G. indicating a return to normal of Ti, T2 and T4.
particular group of patients under discussion, and not to the
entire field of angina and coronary artery disease, the precipitat-
ing factors of which may he as diverse as in bronchial asthma.
In many of our early cases, cessation in the use of tobacco not
only terminated the anginal pain but brought about, as illustrated
in one of our patients, a rapid return to normal of the electro-
cardiographic changes characteristic of coronary artery occlusion
(illustration 1). This apparently indicated a reversibility of the
allergic vascular response in the coronary vessels.
The demonstration in the relationship between clinical im-
provement of symptoms as well as arrest in the progress of
q7t,,-?,.
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vascular disease in our patients with thrombo-angiitis obliterans
and coronary artery involvement following discontinuance in the
use of tobacco on the one hand and the presence of positive skin
reactions as well as specific reagins to tobacco on the other,
clearly satisfies the basic postulates of an allergic mechanism.
It moreover laid the ground work for further studies of other
clinical expressions of tobacco hypersensitiveness, such as border-
line cases of thrombo-angiitis obliterans i.e., cases whOse vascular
symptoms begin between the ages of 45 to 55 and in whom there
may be an associated early arterio-sclerosis, peripheral vascular
disease with no evidence of thrombo-angiitis obliterans associated
with arterio-sclerosis and superimposed tobacco allergy, where
both in our experience and that of Green approximately 42 to 45
per cent of the patients showed tobacco reactions,—a much
lower percentage than that found in thrombo-angiitis obliter-
ans-—, certain types of migrating phlebitis, paroxysmal tachy-
cardia, auricular fibrillation, migrain, urticaria, angio-neurotic
edema, various gastro-intestinal manifestations similar to those
seen with food hypersensitiveness, bronchial asthma, vaso-motor
rhinitis and dermatitis due to handling of tobacco etc.
In practically all of these conditions, some of which have
already been reported in detail and others which will appear in
future publications, positive skin reactions and tobacco reagins
could be correlated with the clinical fact that cessation in the use
of tobacco was followed by disappearance of symptoms. This
was especially true in those instances where tobacco allergy was
uncomplicated by polyvalent sensitivity. In contrast however,
to the straightforward cases of thrombo-angiitis obliterans under
45 years of age where discontinuance of tobacco was of major
importance in influencing the course and prognosis of the disease,
in the borderline thrombo-angiitis group and in the early cases
of arterio-sclerosis in whom tobacco hypersensitiveness co-
existed, in spite of the striking symptomatic relief following re-
moval of tobacco in the majority of these patients, rapidity in
the progress of the underlying degenerative disease, determined
the final outlook. In this respect some of these patients behaved
like the advanced cases of arterio-sclerosis, very few of which
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reacted to anything, in whom the vascular process is no longer
reversible and abstention from tobacco even in the presence of
allergy can no longer influence the irreversible stage which
dominates the clinical picture.
In addition to these investigations, studies of the immuno-
logical aspect of the tobacco allergen were undertaken in asso-
ciation with Witebsky (18) in order to solve the question of its
specificity not only clinically but also experimentally.
The clinical-immunological phase of tobacco specificity was
investigated in cases which presented multiple hypersensitive-
ness to different allergens including tobacco, by quantitative
titration and absorption of reagins. Inasmuch as ordinary
passive transfer merely affords qualitative information as to the
prevailing reagins, determination of the concentration of the
respective reagins by means of titration and absorption by the
corresponding allergens gives us a true picture of their inde-
pendence or interdependence, which in the latter instance may
be the result of stimulation by biochemically related antigens.
The sera of two cases, one with coronary artery disease and the
other with family periodic paralysis, who in addition to tobacco,
showed multiple sensitivity associated with corresponding reagins
were studied.
The results in the first patient following serum titration, indi-
cated a high concentration of tobacco reagins. Preliminary
addition of tobacco extract to the serum in vitro, inhibited sensi-
tization of normal skin on passive transfer, indicating absorption
of the related antibody.
In a second patient, in whom quantitative titration of serum
revealed good concentrations of reagins for timothy, tobacco
and corn, prior addition of timothy extract to serum in vitro,
exhausted the reagins for timothy and corn but not for tobacco,
indicating that the former was an independent antibody whereas
the corn was a partial antibody sharing its existence with timothy
reagins. Previous addition of tobacco extract to the serum,
fixed the reagins for tobacco but not for timothy. Addition, of
corn extract to this serum absorbed the corn antibody but did
not influence the tobacco or the timothy antibody.
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These experiments clearly indicated that the tobacco and
timothy reagins were specific and independent, and that con-
sequently the skin reactions were due to a specific reaginic
mechanism.
This having been established, we next investigated the histo-
logical nature of the tissue changes of the immediate urticarial
and the delayed reactions following intradermal tests with
tobacco and saline controls in a group of ten patients with
thrombo-angiitis obliterans, one with acute coronary thrombosis
and one with migrating phlebitis. None of these patients with
the possible exception of the last had a personal or family history
of allergy.
The microscopic studies as reported by Dr. Samuel Peck,2
showed eosinophiles varying in numbers in the immediate urti-
canal wheals produced by the tobacco allergen in six of eight
cases of thrombo-angiitis obliterans and in one case of migrating
phlebitis. The biopsies of two patients with thrombo-angiitis
obliterans and one 37 year old patient with coronary artery
thrombosis, who developed delayed reactions, showed an acute
dermatitis.
To further corroborate the exciting role of tobacco, one of the
patients with thrombo-angiitis obliterans, giving a delayed
eczematous type of local reaction when tested, was given a
series of 15 injections of tobacco subcutaneously. Following the
last injection he developed a generalized eczema and exacerba-
tion of the symptoms of thrombo-angiitis obliterans from which
he had been free for two years because of abstention from tobacco.
These findings served to emphasize that tobacco extract far
from being a primary urticariogenic substance, like histamine
or other drugs, is an allergen capable of evoking in susceptible
individuals both immediate and delayed reactions, the specificity
of which is substantiated by the presence of serum reagins and
local eosinophilic tissue response. This specificity was likewise
substantiated by Lounsbury and Oughterson (20).
The experimental phase in our investigation of tobacco allergy
2 Dr. Peck is a member of the dermatologic staff and assistant dermatopathol-
ogist of Mount Sinai Hospital.
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deals with the sensitizing effect of tobacco in rats. In a recent
report (21) we published studies in 22 animals, 15 of which were
injected with pooled tobacco extracts employed in testing our
patients, and seven normal controls. These animals were
inoculated with 0.1 to 0.5 cc. of tobacco extracts intraperitoneally
every day for six to twelve weeks within which time 33 per cent
developed gangrene of the toes. Similar results had been re-
ported by Friedlander, Silbert and Laskey (22), who used de-
nicotinized Sano tobacco which produced lesions in 68 per cent
of their male rats. None of our female control rats have ever
FIG. 2. GANGRENE OF TOES IN MALE RATS INJECTED FOR TEN WEEKS WITH 0.5 TO
0.1 CC. OF ToBAcco EXTRACT INTRAPERITONALLY
developed toe lesions, nor have we been able to demonstrate any
sensitization to tobacco in the female species.
To elucidate the nature of the toe lesions we studied the ex-
cised intestinal strip obtained from the male rats, who had
developed gangrene, according to Schultz-Dale technique so as
to determine whether the tissues of the injected animals had been
sensitized to tobacco. These intestinal segments were suspended
in a bath containing Tyrode solution and tobacco extract added
in amounts arrived at by previous titration of normal intestinal
strips similarly prepared, derived from uninjected animals. The
results showed that intestinal strips of animals who had developed
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gangrene of the toes were sensitized to tobacco. Out of six male
rats injected with tobacco that did not develop gangrenous lesions
of the toes, only three showed tobacco sensitization. In four
FIG. 3. (I) POSITIVE ANAPHTLACTIC REACTION OF INTESTINAL STRIP FROM RAT 16
FOLLOWING TIlE INTRODUCTION OF 0.4 CC. OF TOBACCO EXTRACT
FIG. 4. (II) Repetition of the reaction on the same strip, indicating that the
gut had not been completely desensitized by the first dose of 0.4 cc. of tobacco
extract.
(III) The same intestinal strip, following reaction in experiment two, giving
a negative response to 0.4 cc. of tobacco extract indicating that the gilt had been
desensitized, followed by demonstration that strip still able to contract on admin-
istration of pilocarpine.
rats who in addition to tobacco were injected with horse dander,
eggwhite and ragweed, no evidence of sensitization to any of
these substances could be demonstrated. In none of the seven
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uninjected Control animals, both male and female was there any
reaction to tobacco extract demonstrable with doses two to three
times as great as that used in testing the intestinal strip of the
sensitized rats (illustrations 2, 3 and 4).
SUMMARY AND CONCLUSION
A review of these observations indicates that positive skin
tests with tobacco prepared according to the method described,
represent true immunological reactions. This was demon-
strated by (a) the presence of tobacco reagins in patients reacting
positively; (b) specific absorption of these reagins by corre-
sponding tobacco allergens in cases with multiple sensitization;
(c) by the induction of a characteristic local eosinophilic reaction
in the immediate urticarial response in patients with thrombo-
angiitis obliterans, coronary artery disease and migrating phle-
bitis tested intradermally with tobacco.
In addition it was demonstrated experimentally that about 33
per cent of male rats injected daily by the intraperitoneal route,
with the same tobaccos employed in testing our patients, devel-
oped gangrene of the toes.
These animals were shown to be sensitized to tobacco by the
Schultz-Dale technique.
On the clinical side, investigations of various types of vascular
involvement represented by thrombo-angiitis obliterans in which
tobacco played a major role, a group of cases with peripheral
vascular disease due basically to arterio-sclerosis in whom
tobacco smoking contributed to the pain and intermittent
claudication, certain types of angina pectoris with and without
coronary artery disease, paroxysmal tachycardia and auricular
fibrillation etc., disclosed positive reactions to tobacco with
corresponding reagins, as follows:
Of one hundred and forty cases with thrombo-angiitis obliterans
tested with ragweed and timothy pollen, horse dander and to-
bacco, 68 per cent gave positive reactions to tobacco only of one
plus and over and 44 per cent of these had reagins for tobacco.
An additional 10 per cent gave plus minus reactions resulting
in a total of 78 per cent of thrombo-angiitis obliterans cases
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reacting to tobacco only. This is in contrast to 9 per cent of
reactions to tobacco only in 400 normal control smokers tested
with the same number of allergens.
Twelve patients with thrombo-angiitis obliterans tested with
nicotine tartrate 1:10,000 and 1:5000 gave completely negative
skin reactions.
Of one hundred cases with coronary artery disease and angina
pectoris 44 per cent reacted to tobacco and 71 per cent out of a
group of fourteen cases had reagins to tobacco.
It is possible to infer from these findings that tobacco allergy
plays an important role in certain forms of vascular disease as
well as symptoms referable to other systems such as respiratory,
gastro-intestinal, skin etc. Since the positive reactions can be
correlated with the fact that in the patients studied and particu-
larly in those with thrombo-angiitis obliterans, angina pectoris
with and without coronary artery disease, discontinuance of
smoking causes an arrest in the progress of the disease and
resumption calls forth an exacerbation of all symptoms, they
assume etiological significance.
Although with the methods available it has been impossible
to adduce any demonstrable proof of sensitization to nicotine as
such, the question of hypersensitiveness to this alkaloid of tobacco
on theoretical grounds cannot be completely dismissed. As
we have previously indicated (4), sensitiveness to drugs and
chemicals may exist irrespective of skin reactions. Aside how-
ever from its possible sensitizing effect, the pharmacological
action of nicotine in all probability plays an accessory rOle
through its constrictive influence on blood vessels with a con-
sequent diminution in blood flow in the tissues involved. Such
a result common in all smokers, is however transitory in normal
persons. In itself it evokes no notable symptoms, but may
become of utmost importance in the evolution of pathological
tissue changes in persons allergic to tobacco. In the latter,
tobacco hypersensitiveness may possibly intensify the pharma-
cological action of nicotine. Whether tobacco allergy is the
only factor operative in the precipitation of thrombo-angiitis
obliterans and certain types of coronary artery involvement,
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or whether it is an important synergist in an underlying metabolic
disturbance, or perhaps some non-specific infection which may
have acted as a preparatory agent in establishing these vascular
shock organs similar to that which obtains in the Shwartzman
phenomenon, it is impossible to say. Its exciting role however,
is suggested immunologically and clinically by the evidence
presented.
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DISCUSSION
DR. MARION B. SULZBERGER, New York: Most of you here know that I have
been interested in this subject for a number of years. Unfortunately, I have not
had the opportunity to pursue my work because of lack of clinical material, and
Dr. Harkavy is to be complimented for the intensive way in which he has devoted
himself to this research. I think this problem of fundamental significance.
It has a practical value because of the importance of the vascular and other
diseases concerned; and it is important in immunologic theory as well.
Dr. Harkavy has presented such a wealth of material that I, who am well ac-
quainted with his subject, have had some difficulty in absorbing all of his presen-
tation. I am sure that some of you must have had similar difficulties, so I will
recapitulate.
One knows that the intracutaneous injection of tobacco extracts produces
urticarial skin reactions in a fairly high percentage of adult individuals. For-
merly one assumed that these reactions were perhaps due to irritation, to some
primarily irritating substances in the extracts. That was all one knew about it
and one let it go at that.
Proof that these reactions to skin tests with tobacco are due to acquired speci-
fic sensitization must of course be based upon the demonstration that individuals
not previously exposed to the allergen do not as a rule evidence these skin reac-
tions. In other words, it must be shown that the skin reaction is due to a sen-
sitivity acquired through previous acquaintance with the specific substance.
With tobacco, as with such ubiquitous agents as poison ivy and the tubercle bacil-
lus, it is impossible in this country to get a group of adult individuals who have
surely never been exposed to the agent, if one excludes new-born infants. All
of us have been exposed to tobacco, whether we smoke or not. One cannot find
any community in which the individuals have not been exposed to tobacco smoke
and tobacco dust. Therefore, if we exclude the infants—because of the possible
differences in the reaction-capacity of the infant's skin—we have no non-exposed
group to use as controls. The next best study which is indicated in order to es-
tablish the influence of the exposure factor is to attempt to correlate the incidence
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of tobacco skin-reactions to the degree of exposure to tobacco. And that is what
Dr. Harkavy and I did. We both found a marked increase in incidence of skin-
reactions in smokers as compared with non-smokers; thus establishing that the
factor of specific exposure is of importance in the production of the skin reaction.
Moreover, it could be shown that the skin-reaction was not due to the nicotine;
that the extracts reacted to heat, etc., like other known allergens; and that,
within certain limits, the incidence of reactions increased with the age of the
group tested. On the whole, one may say that there is pretty adequate evidence
that the majority of the urticarial skin-reactions produced on testing with to-
bacco extracts are based on some form of specific sensitization or cutaneous
allergy.
The second part of the problem is the relationship between these allergic skin-
reactions and disease. Many skin-reactions are truly allergic and nevertheless
have no connection with disease. The question therefore arose: Are there any
diseases in which one can incriminate tobacco clinically—where exposure to to-
bacco causes exacerbations and where elimination of smoking produces relief?
And are the skin-reactions to tobacco different in these diseases than in others,
or than in normal persons? If in testing the diseases in which tobacco has been
known to be of clinical importance we obtain a higher incidence of skin-reactions
to tobacco than in other diseases or than in normal persons then we have sub-
mitted additional evidence not only that there is some connection between
tobacco and the disease, but also that there is some connection between allergy
and the disease.
I believe that Dr. Harkavy's figures,—as well as those in my all too inadequate
and too small series,—demonstrate a connection between allergy to tobacco and
the production of disease in cases of thrombo-angiitis obliterans. The studies of
recent years have served to support this conclusion which Dr. Harkavy and I
first expressed about 7 years ago. ("Studies in tobacco hypersensitivity. I. A
comparison between reactions to nicotine and to dcnicotinized tobacco extract"
(with the assistance of B. Scholder and Emanuel Feit), Jour, of Immun., 24:
No. 1, January, 1933; "Studies in tobacco hypersensitivity. IT. Thromboarigiitis
obliterans with positive urticarial skin reactions and negative reagin findings."
Marion B. Sulzberger and Emanuel Feit, Jour. of Immun., 24: no. 5, May, 1933;
and "Symposium: recent studies on the effects of tobacco in man. Recent im-
munologic experiments in tobacco hypersensitivity," Bulletin of the New York
Academy of Medicine, May, 1933, second series, 9: no. 5, pp. 294—317; and J. A.
M. A. 102: 11, 1934.)
In confirmation of these findings in human beings we may now cite the results
in experimental animals. As a matter of fact there are probably few allergic
diseases of human beings in which animal experiments have produced such con-
vincing results. After years of failure of toxicologic experiments to produce in
animals the vascu1r diseases known to be attributable to tobacco smoking in
man, the allergic approach immediately records signal success. The very denico-
tinized allergenic tobacco extracts which elicited the skin reactions in human be-
ings were injected into rats, with the technic designed to study, not toxic effects,
but allergic sensitization. The results are extraordinarily close to the human
disease. For not only were vascular and gangrenous lesions produced, but there
was specific sensitization to the tobacco allergen, as demonstrated by the Schultz-
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Dale reaction. Moreover, both the sensitization to tobacco and the gangrene
occurred almost exclusively if not exclusively in males, a point of striking similarity
to thromboangiitis obliterans.
I believe that these animal studies not only round out the evidence in favor of
tobacco allergy as an important mechanism in the production of certain vascular
diseases, but have also brought to light an object which presents entirely new
opportunities for important studies in endocrinology and immunology. For it seems
to me we have here for the first time a sex-linked form of susceptibility to allergic
sensitization.
DR. J. GARDNER HoPKINs, New York: There are one or two things especially
I wish Dr. Harkavy would tell us about in closing. Tobacco, is, of course, a
complex substance. I assume Dr. Harkavy used an aqueous extract containing
nicotine. Was the nicotine active? In smoking we do get some nicotine, but
must get very little protein. In chewing tobacco one might absorb a great deal
of protein. Were not tests made of tobacco chewers?
Da. JOSEPH HARKAVY, New York: In answer to the question of sensitization
to tobacco of guinea pigs vs. rats, I should like to make the following observa-
tions. The work with rats was suggested by the experiments of Rothlin3 and
McGrath,4 who produced gangrenous lesions in the rats by the use of ergotamine
tartrate.
McGrath found that injection of ergotamine tartrate which produced pe-
ripheral gangrene in rats could be prevented by the simultaneous injection of
theelin. These results however could not be confirmed by Loewe and Lenke.5
Nevertheless the work of McGrath stimulated Friedlander and Silbert, who were
interested primarily in the production of thrombo-angiitis obliterans by injection
of tobacco or nicotine, to employ albino rats in place of rabbits and cats which had
failed to respond to inoculations with tobacco and nicotine. Following repeated
injections with Sano tobacco, from which 60 per cent of the nicotine had been
removed, 33 out of 48 of their male rats developed gangrene of the toes, but none
of the females. We repeated these experiments using tobacco extracts employed
in testing our patients and were able to produce gangrenous lesions in only 33 per
cent of our male rats. In this connection I wish to point out the fact that we
could sensitize our rats in the spring, summer and fall but not during the winter.
We tried to repeat the same experiments in guinea pigs but failed to obtain toe
lesions. While in the midst of this work there appeared a report in the Journal
of Immunology of November 1937, by Seastone, Loring et al, dealing with results
of successful sensitization of guinea pigs with tobacco mosaic virus and of shock-
ing such anaphylactic animals with an extract of normal tobacco plant. If how-
ever, they sensitized the guinea pigs with mosaic tobacco virus which had been
ultracentrifuged four times, they could no longer shock them with normal tobacco
extract. It is obvious therefore that by four ultracentrifugations they had
Rothlin, E., Pharm. and Exp. Therap., 36: 657, 1929.
McGrath, J. G., Arch. mt. Med., 55:942, 1935.
Loewe, L., and Lenke, S. E., Journ. Pharm. and Exp. Ther., 63: 93. 1938.
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gotten rid of practically all of the tobacco protein and hence the animals were
sensitized to the mosaic virus oniy and no longer responded to normal tobacco
extract. These experiments indicated however, that guinea pigs can be made
anaphylactic to tobacco but they do not develop toe lesions such as seen in rats.
I believe that the gangrenous toes of our rats represent a form of Arthus phenom-
enon.
Stanley's work with tobacco mosaic virus however, raised the question in my
mind as to whether our cases with thrombo-angiitis obliterans might not have
developed their lesions as a result of sensitization to the virus of tobacco mosaic
while smoking, since mosaic infected tobaccos are not infrequently found on the
market and used in making cigarettes etc. Unfortunately it was impossible for us
to prove this point, because we were unable to obtain the pure mosaic virus which
was subjected to four ultracentrifugations. The tobacco mosaic virus extract
with which we tested our patients with thrombo-angiitis obliterans and obtained
positive skin reactions contained tobacco protein, so that we could not tell
whether the results were due to tobacco or the virus.
As far as the effect of nicotine is concerned all that I can say is, that it is im-
possible to state whether it will produce the pathological changes seen in thrombo-
angiitis obliterans. Theoretically hypersensitiveness to nicotine cannot be
completely dismissed. Actually, skin tests with nicotine in our patients have
thus far been negative. We know however, that the pharmacological action of
this alkaloid is characterized by vaso-constriction. This holds true for normal
persons as well as patients with thrombo-angiitis obliterans. The nicotine effect
in most normals however is transitory, limited to the duration of smoking and not
followed by any untoward symptoms. In view of the fact that in some indi-
viduals, smoking is succeeded by pathological tissue changes, there must be more
than the mere pharmacologic action of nicotine involved. That additional factor
in my mind, is hypersensitiveness to tobacco. It is conceivable that in persons
allergic to tobacco, the pharmacological action of nicotine may be prolonged
and intensified. Through its constrictive effect on blood vessels which are the
seat of allergic reactions with the resulting diminution in blood flow, a state of
anoxemia of the vessel wall may ensue and thus provide the groundwork for
thrombosis.
I am not prepared to make any statement as to the action of elements in
tobacco other than nicotine because I have not worked with any of them. I
should not be surprised however if they did play some synergistic role. We must
realize that in tobacco we are dealing with a very complex substance.
